Annovis Bio, Inc. ( ANVS) - Key Metrics
ANVS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.40 | -$824.02 | -$824.02 |
| 2026Q1 | $0 | -$0.63 | -$0.32 | -$0.32 |
| 2025Q4 | $0 | -$0.40 | -$0.36 | -$0.36 |
| 2025Q3 | $0 | -$0.37 | -$0.18 | -$0.18 |
| 2025Q2 | $0 | -$0.32 | -$0.26 | -$0.26 |
ANVS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.16 |
| 2026Q1 | 0% | -0.88 |
| 2025Q4 | 0% | -2.16 |
| 2025Q3 | 0% | -1.40 |
| 2025Q2 | 0% | -1.70 |
ANVS
Price: $1
52 week price:
Earnings Per Share: -1.61 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 103127
Market Capitalization: 50.2 million